Executive Summary of CDDF-EORTC Joint Workshop on Innovation and Access in Rare Cancers

The Cancer Drug Development Forum (CDDF) shared on LinkedIn:

“Executive Summary: CDDF-EORTC Joint Workshop on Innovation and Access in Rare Cancers (23-24 September 2024, Amsterdam, NL)

The Cancer Drug Development Forum (CDDF) is delighted to announce that the executive summary of its recent workshop on Rare Cancers has been published today and is available to all stakeholders.

This collaborative initiative between CDDF and EORTC focused on the current state of play in clinical trials and exchanged multistakeholder perspectives in order to improve access to innovative therapies for patients with rare cancers.

A multi-stakeholder group of experts provided insights on important topics in rare cancers such as the existing challenges, ongoing collaborations, unmet needs, innovative clinical trial designs and potential solutions to improve patient access.

To learn more about our discussions, read the executive summary and feel free to share your thoughts with us.

Read the executive summary.
Have a quick glimpse of the September workshop.”

EORTC shared a post by The Cancer Drug Development Forum (CDDF) on LinkedIn, adding:

“Last month’s CDDF-EORTC Joint Workshop on Innovation and Access in Rare Cancers, led by EORTC President Prof. Winette van der Graaf and Prof. Ruth Plummer, brought together key stakeholders to discuss the current state of play in Clinical Trials. The workshop provided a platform for collaborative insights on improving access to innovative therapies for rare cancer patients.

Read the full executive summary here.”

More posts featuring CDDF and EORTC on oncodaily.com